2m 2m 2m 2m 2m 2m 2m
Arbutus Biopharm (ABUS)
NASDAQ
$4.50-$0.02 (-0.55%)
Price as of Jun 23, 2026 7:26 PM EDT- $892.9MMarket Cap
- 32.55%1-Year Change
- BiotechnologyIndustry
Arbutus Biopharm (ABUS)
$4.50-$0.02 (-0.55%)
Earnings Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 2.82% | ||
12-Month Momentum | 27.41% | ||
3-Month Risk Adjusted Momentum | 16.64% | ||
12-Month Risk Adjusted Momentum | 61.32% |
True Yield
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 27 |